Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · IL0011007189 TA Manufacturing
Open in API
Filings indexed 375 across all filing types
Latest filing 2019-08-14 Report Publication Anno…
Country IL Israel
Listing TA BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical technology company focused on developing and marketing advanced noninvasive neurostimulation treatments for mental health and addictive disorders. The company's core product is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) system, which uses a patented H-coil to stimulate deeper and broader regions of the brain. The technology is designed as a safe and effective non-drug treatment option. The Deep TMS system has received multiple FDA clearances for conditions including Major Depressive Disorder (MDD), anxious depression, and Obsessive-Compulsive Disorder (OCD), for which it was the first noninvasive medical device to receive such clearance. It is also FDA-cleared as an aid for short-term smoking cessation, the first TMS device to be cleared for an addiction indication.

Recent filings

Filing Released Lang Actions
Immediate Report
Report Publication Announcement Classification · 1% confidence The document is a short regulatory filing (2004 chars) from BrainsWay Ltd. The title explicitly states the purpose: 'BrainsWay Ltd. to Host Second Quarter 2019 Financial Results Conference Call on August 26, 2019'. It references the Israel Securities Authority and the Tel Aviv Stock Exchange, indicating a regulatory disclosure. Crucially, the body states, 'Attached hereto is a report on...' and lists a PDF file. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report (in this case, an earnings-related conference call announcement) without containing the full details of the results or transcript itself, should be classified as a Report Publication Announcement (RPA). If it were the transcript, it would be CT; if it were the full results, it might be ER or IR. Since it is merely announcing the call where the results will be discussed, RPA is the most appropriate classification.
2019-08-14 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is explicitly titled "FORM 6-K" and is filed under the Securities Exchange Act of 1934 by a Foreign Private Issuer. Form 6-K is generally used to report material information that the registrant is required to disclose to its home country's regulators or stock exchange, or that it makes available to its shareholders in its home country. This filing is being made for the month of July 2019 and includes an exhibit which is a press release announcing the publication of a study. Since Form 6-K is a general reporting requirement for foreign private issuers and doesn't map directly to the standard US periodic reports (like 10-K or 10-Q), it falls under the general category for miscellaneous regulatory filings that do not fit elsewhere, which is RNS (Regulatory Filings). Although it contains an Earnings Release-like announcement (the study publication), the primary wrapper is the SEC Form 6-K.
2019-07-18 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is an 'Amended report for distorted report sent on date 18/07/2019'. It explicitly states that it is an 'Immediate Report' under Israeli Securities Authority regulations. Crucially, the text ends with 'Attached hereto is a report on *Groundbreaking_Study_Demonstrates_Advantages_of_BrainsWay_Deep_TMS_in_Treating_Major_Depressive_Disorder_FIG3_isa.pdf*'. This structure—a brief notification announcing the publication of an attached document (which appears to be a study result or press release)—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), rather than the full content of the report itself (like ER or AR). Given the context of announcing a specific attached document related to a study, RPA is the most precise fit, as it signals the release of another report.
2019-07-18 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is explicitly titled 'FORM 6-K' and is a 'REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934' for the month of July 2019. Form 6-K filings are generally used to report material information that a foreign private issuer is required to disclose to its home country's securities regulator or stock exchange, or that it makes public in its home country. This type of filing often contains press releases or other material updates not covered by standard US SEC forms like 10-K or 10-Q. The content itself is a press release announcing the publication of a third-party study regarding their Deep TMS product. Since Form 6-K is a specific SEC filing type not explicitly listed in the provided codes (AGM-R, 10-K, AR, etc.), the most appropriate fallback category for a general, non-standard SEC filing that reports material information is 'Regulatory Filings' (RNS). The document is not a standard Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a simple announcement of a report (RPA), but rather the filing itself containing the material news.
2019-07-18 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is very short (2036 characters) and explicitly states: "Attached hereto is a report on*Groundbreaking Study Demonstrates Advantages of BrainsWay Deep TMS in Treating Major Depressive Disorder*" followed by a PDF filename. This structure indicates that the document itself is an announcement about the publication of another report or material, rather than the full content of that material. It is filed with the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE) as an 'Immediate Report' under Regulation 4 for a Foreign Corporation. Since the content is an announcement of a study/report and doesn't fit specific categories like ER, 10-K, or IR, the most appropriate classification based on the 'MENU VS MEAL' rule is Report Publication Announcement (RPA), as it announces the release of information. If RPA were not available, RNS would be the fallback, but RPA is more specific for announcing the publication of a report.
2019-07-18 English
Immediate Report
Regulatory Filings Classification · 1% confidence The document is explicitly titled "FORM 6-K" and is filed under the Securities Exchange Act of 1934 by a Foreign Private Issuer (BRAINSWAY LTD.). Form 6-K is used to report material information that a foreign private issuer is required to disclose to its home country's securities regulator or stock exchange, or that it makes public in its home country. This type of filing is generally used for current reports that do not fit neatly into the periodic reporting requirements of Form 20-F (the annual report equivalent). Since the document contains a press release announcing new clinical data published in a journal, and it is structured as a Form 6-K submission, it functions as a general regulatory disclosure. Reviewing the provided definitions: - It is not a 10-K (Annual Report). - It is not a standalone Audit Report (AR). - It is not a Call Transcript (CT). - It is not a specific Earnings Release (ER) focusing only on quarterly highlights; it's a scientific/clinical update. - It is not a specific Investor Presentation (IP). Form 6-K filings often fall under the general category of 'Regulatory Filings' (RNS) when they announce material, non-periodic information that doesn't fit a more specific category like Director's Dealing (DIRS) or Dividend Notice (DIV). While it contains elements of an announcement (RPA), the primary context is the SEC filing itself (Form 6-K), which serves as the official regulatory vehicle for this information. Therefore, the most appropriate classification for a Form 6-K that doesn't match other specific types is the general regulatory fallback category.
2019-06-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.